Wells Fargo & Company »

Emergent BioSolutions shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2010-12-31 $113k 4.8k 23.37

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Palisade Capital Management
Charles Schwab Investment Management
Geode Capital Management
Acadian Asset Management
Connor, Clark & Lunn Investment Management
Marshall Wace
LSV Asset Management
Prescott Group Capital Management
Morgan Stanley

View all funds holding Emergent BioSolutions